338 related articles for article (PubMed ID: 35192929)
1. Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment.
Srivastava A; Rathore S; Munshi A; Ramesh R
Semin Cancer Biol; 2022 Nov; 86(Pt 1):80-100. PubMed ID: 35192929
[TBL] [Abstract][Full Text] [Related]
2. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeted exosomes for delivery of anticancer drugs.
Raguraman R; Bhavsar D; Kim D; Ren X; Sikavitsas V; Munshi A; Ramesh R
Cancer Lett; 2023 Apr; 558():216093. PubMed ID: 36822543
[TBL] [Abstract][Full Text] [Related]
4. Exosome as a Delivery Vehicle for Cancer Therapy.
Moon B; Chang S
Cells; 2022 Jan; 11(3):. PubMed ID: 35159126
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
[TBL] [Abstract][Full Text] [Related]
7. Exosomes as Anticancer Drug Delivery Vehicles: Prospects and Challenges.
Zhang Y; Li J; Gao W; Xie N
Front Biosci (Landmark Ed); 2022 Oct; 27(10):293. PubMed ID: 36336863
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles in the Development of Cancer Therapeutics.
Sun H; Burrola S; Wu J; Ding WQ
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103
[TBL] [Abstract][Full Text] [Related]
9. Research progress of exosomes as drug carriers in cancer and inflammation.
Feng Q; Zhang Y; Fang Y; Kong X; He Z; Ji J; Yang X; Zhai G
J Drug Target; 2023 Apr; 31(4):335-353. PubMed ID: 36543743
[TBL] [Abstract][Full Text] [Related]
10. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
[TBL] [Abstract][Full Text] [Related]
12. Strategies for Engineering Exosomes and Their Applications in Drug Delivery.
Zhu M; Li S; Li S; Wang H; Xu J; Wang Y; Liang G
J Biomed Nanotechnol; 2021 Dec; 17(12):2271-2297. PubMed ID: 34974854
[TBL] [Abstract][Full Text] [Related]
13. Exosomes and Other Extracellular Vesicles with High Therapeutic Potential: Their Applications in Oncology, Neurology, and Dermatology.
Szwedowicz U; Łapińska Z; Gajewska-Naryniecka A; Choromańska A
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209095
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: Recent advancements and future perspectives.
Ramesh D; Bakkannavar S; Bhat VR; Sharan K
F1000Res; 2023; 12():329. PubMed ID: 37868300
[TBL] [Abstract][Full Text] [Related]
16. Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs.
Chinnappan M; Srivastava A; Amreddy N; Razaq M; Pareek V; Ahmed R; Mehta M; Peterson JE; Munshi A; Ramesh R
Cancer Lett; 2020 Aug; 486():18-28. PubMed ID: 32439419
[TBL] [Abstract][Full Text] [Related]
17. Using exosomes, naturally-equipped nanocarriers, for drug delivery.
Batrakova EV; Kim MS
J Control Release; 2015 Dec; 219():396-405. PubMed ID: 26241750
[TBL] [Abstract][Full Text] [Related]
18. Exosomes: cell-created drug delivery systems.
Familtseva A; Jeremic N; Tyagi SC
Mol Cell Biochem; 2019 Sep; 459(1-2):1-6. PubMed ID: 31073888
[TBL] [Abstract][Full Text] [Related]
19. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
[TBL] [Abstract][Full Text] [Related]
20. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
Meng W; He C; Hao Y; Wang L; Li L; Zhu G
Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
